エクソソーム診断および治療の世界市場レポート 2024

エクソソーム診断および治療の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には28.1%の年間複合成長率（CAGR）で12億8,000万米ドルに成長すると予想されます。予測期間における予想される成長には、いくつかの要因が考えられます。これらには、エクソソームベースの臨床応用の採用の増加、エクソソームとデジタルヘルス技術の統合、進歩を促進する支援的な規制環境、エクソソーム調査を促進する遺伝子編集とRNA治療法の台頭、免疫腫瘍学アプリケーションにおけるエクソソームの役割の拡大などが含まれます。この予測期間に予想される主要な動向には、創薬プロセスにおけるエクソソームの利用、生体模倣エクソソーム工学における革新的なアプローチ、エクソソームベースの製品の商業化への取り組み、治療用貨物のキャリアとしてのエクソソームの活用、がん検診のためのエクソソームベースのリキッドバイオプシー法の使用が含まれます。これらの動向は、予測期間におけるエクソソームの診断と治療の成長に大きな影響を与え、促進すると予測されています。

エクソソーム診断および治療市場の予想される成長は、慢性疾患の有病率の増加によって大きく推進されています。 3か月以上続き、時間の経過とともに悪化する傾向のある慢性疾患は、世界的に重大な健康上の懸念事項です。エクソソームは、診断と治療の両方の機能で利用され、がんにおける有望なバイオマーカーとして浮上しており、より高感度の疾患モニタリングを可能にし、個別化医療へのアクセスを促進します。国立バイオテクノロジー情報センター（NCBI）は、2023年 1月の予測で、2050年までに世界の慢性疾患患者数が1億4,266万人に達すると予測しています。この統計は、慢性疾患の有病率の上昇がエクソソーム診断と治療薬市場の推進において極めて重要な役割を果たしていることを強調しています。

エクソソーム診断および治療市場の上昇軌道は、高齢者人口の増加によってさらに加速されています。「高齢者人口」という用語は、多くの場合人生の後期段階にある、65歳以上の個人を指します。エクソソームは加齢に伴う症状を診断し、対処するための貴重なツールとして機能するため、この人口統計の拡大はエクソソームの診断と治療の需要に大きく貢献しています。特に、2022年10月に世界保健機関（WHO）が発表した報告書は、人口動態の大きな変化を示しており、2030年までに世界中で6人に1人が60歳以上になると予測されています。 2050年までに、世界中で21億人が60歳以上になると推定されています。この人口動態の変化は、高齢者人口の増加がエクソソーム診断および治療市場の成長を促進する大きな影響を浮き彫りにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のエクソソーム診断および治療市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界のエクソソーム診断および治療市場規模実績と成長、2018～2023年
• 世界のエクソソーム診断および治療市場規模と成長予測、2023年から2028年、2033年

第6章 市場セグメンテーション

• 世界のエクソソーム診断および治療市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 機器
• ソフトウェア
• 試薬とキット
• 世界のエクソソーム診断および治療市場、アプリケーション別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 診断用
• 治療用
• 世界のエクソソーム診断および治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 学術調査機関
• 製薬会社およびバイオテクノロジー会社
• 病院と診療所
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のエクソソーム診断および治療市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のエクソソーム診断および治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• エクソソーム診断および治療市場の競合情勢
• エクソソーム診断および治療市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Bio-Techne Corp.
  • Miltenyi Biotec GmBH
  • Malvern Instruments Inc.

第31章 その他の大手および革新的な企業

• BioVision Inc.
• System Biosciences LLC
• Evox Therapeutics Ltd.
• ExCoBio Inc.
• BioCat GmbH
• NanoSomix Inc.
• Exosome Diagnostics Inc.
• Capricor Therapeutic Inc.
• Aethlon Medical Inc.
• Codiak BioSciences Inc.
• NX Pharmagen Inc.
• Exiqon A/S
• Aegle Therapeutic Corporation
• AMS Biotechnology Ltd.
• Cell Guidance Systems

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Exosome diagnostics and therapeutics involve utilizing exosomes-small extracellular particles produced by cells-for both diagnostic and therapeutic purposes. Exosomes are employed in therapeutic applications as a means of delivering targeted medications, particularly within the field of regenerative medicine.

The primary products within the exosome diagnostic and therapeutic market comprise instruments, software, reagents, and kits. Instruments refer to equipment utilized for precise and accurate execution of activities or experiments. These products find diverse applications in diagnostics and therapeutics and cater to various end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, among others.

The exosome diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with an exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.36 billion in 2023 to $0.48 billion in 2024 at a compound annual growth rate (CAGR) of 31.1%. The growth observed in the historical period can be attributed to several key factors. These include significant advancements in biological research, the emergence and development of precision medicine approaches, innovations in biomedical imaging technologies, a strong focus on cancer research and advancements in oncology, and substantial investments made within the healthcare industry. These factors collectively contributed to the growth and progress witnessed during the historical period in the field of exosome diagnostics and therapeutics.

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $1.28 billion in 2028 at a compound annual growth rate (CAGR) of 28.1%. The anticipated growth in the forecasted period can be attributed to several contributing factors. These include the increasing adoption of exosome-based clinical applications, the integration of exosomes with digital health technologies, a supportive regulatory environment fostering advancements, the rise of gene editing and RNA therapeutics furthering exosome research, and the expanded role of exosomes in immuno-oncology applications. Key trends expected in this forecasted period encompass the utilization of exosomes in drug discovery processes, innovative approaches in biomimetic exosome engineering, commercialization initiatives for exosome-based products, leveraging exosomes as carriers for therapeutic cargo, and the use of exosome-based liquid biopsy methods for cancer screening. These trends are projected to significantly influence and drive the growth of exosome diagnostics and therapeutics in the forecasted period.

The anticipated growth of the exosome diagnostic and therapeutic market is strongly driven by the increasing prevalence of chronic diseases. Chronic illnesses, lasting three months or more and prone to deterioration over time, are a significant health concern globally. Exosomes, utilized in both diagnostic and therapeutic capacities, emerge as promising biomarkers in cancer, enabling more sensitive disease monitoring and facilitating the accessibility of personalized medicine. In a projection from January 2023, the National Center for Biotechnology Information (NCBI) indicates a forecasted global count of 142.66 million individuals with chronic diseases by 2050. This statistic underscores the pivotal role played by the rising prevalence of chronic diseases in propelling the exosome diagnostics and therapeutics market.

The upward trajectory of the exosome diagnostic and therapeutic market is further fueled by the increasing size of the geriatric population. The term 'geriatric population' refers to individuals aged 65 years and older, often in the later stages of life. This demographic expansion contributes significantly to the demand for exosome diagnostics and therapeutics, as exosomes serve as valuable tools for diagnosing and addressing age-related conditions. Notably, a report from the World Health Organization (WHO) in October 2022 indicates a profound demographic shift, with one in six individuals projected to be 60 or older by 2030 globally. By 2050, an estimated 2.1 billion people worldwide will be 60 years old or older. This demographic shift underscores the substantial impact of the rising geriatric population on driving the growth of the exosome diagnostic and therapeutic market.

Major companies are actively engaged in developing innovative products, such as sample purification systems, to expand their customer base, boost sales, and drive revenue growth. A sample purification system encompasses a suite of processes and technologies designed to eliminate impurities and contaminants from various sample types, including DNA, RNA, proteins, and other biomolecules. As an illustration, in February 2023, Biological Dynamics Inc., a prominent US-based biotechnology company, introduced ExoVerita-an exosome-isolation platform designed for early disease surveillance and diverse applications. The ExoVita Pancreas assay, part of this platform, identifies specific exosomal protein indicators and has demonstrated the ability to detect Stage 1 and Stage 2 pancreatic ductal adenocarcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company is actively validating these findings through the ExoLuminate registry trial (NCT05625529), recruiting high-risk PDAC patients to assess the clinical value of the test.

Major players in the exosome diagnostic and therapeutic market are adopting a strategic partnership approach to enhance the exosome purification process. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. A noteworthy example is the collaboration between Cytiva, a prominent US-based biotechnology company, and RoosterBio Inc., also a US-based biotechnology company. Announced in October 2023, this partnership aims to improve the exosome purification process, a current bottleneck hindering the widespread adoption of promising gene therapies and other innovative modalities. By combining the strengths of both entities, the collaboration seeks to address a significant challenge limiting the use of exosomes in therapeutic applications, particularly as carriers for gene therapies and biologics. The envisioned outcome is the advancement of large-scale manufacturing capabilities for exosomes.

In November 2021, Lonza Group AG, a renowned Switzerland-based company specializing in contract manufacturing and development solutions, successfully acquired an exosome manufacturing facility from Codiak BioSciences Inc. for a sum of $65 million. This strategic acquisition by Lonza is intended to broaden its scope of services, encompassing exosome assay and process development, analytics, and manufacturing services. Moreover, Lonza seeks to expedite advancements in exosome production, purification, and analytics through this acquisition. Codiak BioSciences Inc., a US-based clinical-stage biopharmaceutical company, is known for its expertise in developing exosome-based therapeutics.

Major companies operating in the exosome diagnostic and therapeutic market report are Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc. , Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.

North America was the largest region in the exosome diagnostic and therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Diagnostic And Therapeutic Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome diagnostic and therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The exosome diagnostic and therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Instruments; Software; Reagents And Kits
• 2) By Application: Diagnostics; Therapeutic
• 3) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End Users
• Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; Bio-Techne Corp.; Miltenyi Biotec GmBH; Malvern Instruments Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exosome Diagnostic And Therapeutic Market Characteristics

3. Exosome Diagnostic And Therapeutic Market Trends And Strategies

4. Exosome Diagnostic And Therapeutic Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Exosome Diagnostic And Therapeutic Market Size and Growth

• 5.1. Global Exosome Diagnostic And Therapeutic Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Exosome Diagnostic And Therapeutic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Exosome Diagnostic And Therapeutic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Exosome Diagnostic And Therapeutic Market Segmentation

• 6.1. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Instruments
• Software
• Reagents And Kits
• 6.2. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diagnostics
• Therapeutic
• 6.3. Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Hospitals And Clinics
• Other End Users

7. Exosome Diagnostic And Therapeutic Market Regional And Country Analysis

• 7.1. Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Exosome Diagnostic And Therapeutic Market

• 8.1. Asia-Pacific Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Exosome Diagnostic And Therapeutic Market

• 9.1. China Exosome Diagnostic And Therapeutic Market Overview
• 9.2. China Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Exosome Diagnostic And Therapeutic Market

• 10.1. India Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Exosome Diagnostic And Therapeutic Market

• 11.1. Japan Exosome Diagnostic And Therapeutic Market Overview
• 11.2. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Exosome Diagnostic And Therapeutic Market

• 12.1. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Exosome Diagnostic And Therapeutic Market

• 13.1. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Exosome Diagnostic And Therapeutic Market

• 14.1. South Korea Exosome Diagnostic And Therapeutic Market Overview
• 14.2. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Exosome Diagnostic And Therapeutic Market

• 15.1. Western Europe Exosome Diagnostic And Therapeutic Market Overview
• 15.2. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Exosome Diagnostic And Therapeutic Market

• 16.1. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Exosome Diagnostic And Therapeutic Market

• 17.1. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Exosome Diagnostic And Therapeutic Market

• 18.1. France Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Exosome Diagnostic And Therapeutic Market

• 19.1. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Exosome Diagnostic And Therapeutic Market

• 20.1. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Exosome Diagnostic And Therapeutic Market

• 21.1. Eastern Europe Exosome Diagnostic And Therapeutic Market Overview
• 21.2. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Exosome Diagnostic And Therapeutic Market

• 22.1. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Exosome Diagnostic And Therapeutic Market

• 23.1. North America Exosome Diagnostic And Therapeutic Market Overview
• 23.2. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Exosome Diagnostic And Therapeutic Market

• 24.1. USA Exosome Diagnostic And Therapeutic Market Overview
• 24.2. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Exosome Diagnostic And Therapeutic Market

• 25.1. Canada Exosome Diagnostic And Therapeutic Market Overview
• 25.2. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Exosome Diagnostic And Therapeutic Market

• 26.1. South America Exosome Diagnostic And Therapeutic Market Overview
• 26.2. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Exosome Diagnostic And Therapeutic Market

• 27.1. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Exosome Diagnostic And Therapeutic Market

• 28.1. Middle East Exosome Diagnostic And Therapeutic Market Overview
• 28.2. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Exosome Diagnostic And Therapeutic Market

• 29.1. Africa Exosome Diagnostic And Therapeutic Market Overview
• 29.2. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

• 30.1. Exosome Diagnostic And Therapeutic Market Competitive Landscape
• 30.2. Exosome Diagnostic And Therapeutic Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Lonza Group AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bio-Techne Corp.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Miltenyi Biotec GmBH
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Malvern Instruments Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Exosome Diagnostic And Therapeutic Market Other Major And Innovative Companies

• 31.1. BioVision Inc.
• 31.2. System Biosciences LLC
• 31.3. Evox Therapeutics Ltd.
• 31.4. ExCoBio Inc.
• 31.5. BioCat GmbH
• 31.6. NanoSomix Inc.
• 31.7. Exosome Diagnostics Inc.
• 31.8. Capricor Therapeutic Inc.
• 31.9. Aethlon Medical Inc.
• 31.10. Codiak BioSciences Inc.
• 31.11. NX Pharmagen Inc.
• 31.12. Exiqon A/S
• 31.13. Aegle Therapeutic Corporation
• 31.14. AMS Biotechnology Ltd.
• 31.15. Cell Guidance Systems

32. Global Exosome Diagnostic And Therapeutic Market Competitive Benchmarking

33. Global Exosome Diagnostic And Therapeutic Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market

35. Exosome Diagnostic And Therapeutic Market Future Outlook and Potential Analysis

• 35.1 Exosome Diagnostic And Therapeutic Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Exosome Diagnostic And Therapeutic Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Exosome Diagnostic And Therapeutic Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer